Related Experiment Videos

Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?

Sebastian L Johnston1, Richard J Martin

  • 1Department of Respiratory Medicine, National Heart and Lung Institute and Wright Fleming Institute of Infection and Immunity, Imperial College London, Norfolk Place, London W2 1PG, UK. s.johnston@imperial.ac.uk

American Journal of Respiratory and Critical Care Medicine
|June 18, 2005
PubMed

Insights

Atypical bacterial infections, including Chlamydophila pneumoniae and Mycoplasma pneumoniae, may play a role in asthma development. Further research is needed to confirm this link and explore antibacterial treatments for asthma management.

Area of Science:

  • Respiratory Medicine
  • Infectious Diseases
  • Immunology

Background:

  • The association between atypical bacterial respiratory pathogens and asthma pathogenesis is debated.
  • Existing literature on Chlamydophila pneumoniae and Mycoplasma pneumoniae in asthma shows conflicting evidence.
  • Diagnostic challenges in identifying atypical infections hinder research clarity.

Purpose of the Study:

  • To review current evidence linking atypical bacterial infections to asthma pathogenesis.
  • To discuss potential biological mechanisms underlying this association.
  • To explore the role of antibacterial therapy in asthma management and highlight research needs.

Main Methods:

  • Literature review of studies investigating atypical bacteria and asthma.
  • Analysis of biological mechanisms potentially connecting infection and disease.
  • Discussion of therapeutic implications and study design recommendations.

Main Results:

  • Evidence suggests a potential role for atypical bacteria in asthma development.
  • Biological plausibility exists for mechanisms linking infection to airway inflammation.
  • Current evidence is limited by study design and diagnostic difficulties.

Conclusions:

  • Atypical bacterial infections warrant further investigation in the context of asthma.
  • Well-designed studies are crucial to elucidate the role of these pathogens and inform treatment strategies.
  • Antibacterial therapy may hold potential for asthma management, pending further evidence.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...